Blog Entry List

North Carolina Department of Health and Human Services (DHHS) developed a program to reimburse primary care providers (PCP) with federal funds for providing medical care for COVID-19 related services to uninsured North Carolina residents. 

North Carolina’s Breast and Cervical Cancer Control Program has changed the criteria to allow additional providers who screen and diagnose women for breast and cervical cancer to refer to Breast and Cervical Cancer Medicaid.

As NC Medicaid moves forward with its planned implementation of NC Medicaid Managed Care, it is important for enrolled providers to act now to thoroughly review their individual and organization provider enrollment record in NCTracks.

The North Carolina Department of Health and Human Services and North Carolina AHEC are offering two monthly evening webinar series to help prepare providers, practice managers and quality managers engage with NC Medicaid. 

Amended policies will post to the NC Medicaid Clinical Coverage Policies website with an effective date of Oct. 1, 2020. 

The North Carolina Department of Health and Human Services announced the launch of a COVID-19 Exposure Notification app called SlowCOVIDNC. The app will help North Carolinians slow the spread of the virus by alerting them when they may have been exposed to someone who has tested positive for COVID-19.

This bulletin replaces SPECIAL BULLETIN COVID-19 #119 in its entirety.

Strong infection prevention and control practices are critical to reducing the transmission of COVID-19 within long-term care facilities. NC DHHS is reiterating its expectation that providers participate in the infection prevention and control activities. 

CMS and the American Medical Association have released a CPT code for an antigen test designed to detect proteins from the virus that causes COVID-19 in respiratory specimens. NC Medicaid is adding this CPT code to NCTracks for medically necessary laboratory testing effective Sept. 1, 2020.

Effective Sept. 1, 2020, the North Carolina Medicaid and NC Health Choice Programs will cover Oncotype Dx and EndoPredict genomic tests used for breast cancer treatment as part of Clinical Coverage policy 1S-7, Gene Expression Profiling for Breast Cancer.

Guidelines for Evidenced-Based Synagis® Prophylaxis, Prior Approval Requests, Dose Authorization, Pharmacy Distributor Information, Provider Information, Submitting a Request to Exceed Policy and Technical Support.

Medicaid/CHIP providers who have not yet submitted their applications for federal Provider Relief Fund are encouraged to apply. The deadline is Sunday, Sept. 13, 2020.

NC-MIPS is Open for Program Year 2020, Program Year 2020 Webinar Series and The Security Risk Analysis (SRA)  

NC Medicaid is reimbursing COVID-19 testing costs for individuals without insurance who enroll in the NC Medicaid Optional COVID-19 Testing (MCV) program. 

Providers are required by State Health Director Order to report all results, positive and negative, of diagnostic testing for SARS-CoV-2, the virus that causes COVID-19.